KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maxlinear (MXL) Change in Accured Expenses (2016 - 2025)

Maxlinear (MXL) has disclosed Change in Accured Expenses for 16 consecutive years, with $7.9 million as the latest value for Q4 2025.

  • Quarterly Change in Accured Expenses rose 476.0% to $7.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $34.8 million through Dec 2025, up 3682.59% year-over-year, with the annual reading at $34.8 million for FY2025, 3682.59% up from the prior year.
  • Change in Accured Expenses for Q4 2025 was $7.9 million at Maxlinear, up from -$2.2 million in the prior quarter.
  • The five-year high for Change in Accured Expenses was $50.4 million in Q2 2022, with the low at -$38.2 million in Q4 2023.
  • Average Change in Accured Expenses over 5 years is $4.2 million, with a median of $6.1 million recorded in 2021.
  • The sharpest move saw Change in Accured Expenses skyrocketed 920.95% in 2022, then tumbled 1511.95% in 2025.
  • Over 5 years, Change in Accured Expenses stood at -$11.1 million in 2021, then plummeted by 49.61% to -$16.6 million in 2022, then plummeted by 130.52% to -$38.2 million in 2023, then surged by 94.52% to -$2.1 million in 2024, then surged by 476.0% to $7.9 million in 2025.
  • According to Business Quant data, Change in Accured Expenses over the past three periods came in at $7.9 million, -$2.2 million, and $20.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.